Abstract. The NAD(P)H:quinone oxidoreductase 1 (NQO1) enzyme is implicated in protection against oxidative stress and carcinogenesis. NQO1 C609T genetic polymorphism was reported to be associated with an increased risk for cancers, including breast cancer. However, there is still lack of evidence whether higher oxidative stress occurs in breast tissues of patients with NQO1 609 C/T and/or T/T genotypes. Mitochondrial DNA (MtDNA) 4,977-bp deletion, the most common mutation of mtDNA, was frequently detected in post-mitotic tissues of aged subjects and associated with oxidative damage. In this study, we detected the mtDNA 4,977-bp deletion in 60 breast cancers and corresponding non-cancerous breast tissues. The incidence of the common 4,977-bp deletion in non-cancerous breast tissues (48.3%) was higher than that in breast cancer (5.0%). Moreover, 63.4% of the breast cancer patients with NQO1 C/T or T/T genotypes had the deletion in their non-cancerous breast tissues. The mtDNA deletion was more frequently detected in breast tissue of NQO1 C/T carriers (65.2%) and T/T carriers (61.1%) as compared with the NQO1 C/C carriers (15.8%, P=0.003). Similar results were observed in the <50 years old (y/o) group (P=0.06) and the ≥50 y/o group (P=0.005). Our findings suggest that mtDNA 4,977-bp deletion associated with NQO1 deficiency is involved in carcinogenesis and progression of breast cancer.
Introduction
NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase, EC 1.6.99.2) is a cytosolic flavoenzyme that catalyzes twoelectron reduction of a broad range of substrates including quinones, quinone-imines and nitro-compounds (1) . The enzyme is generally considered as a detoxification enzyme because of its ability to reduce reactive quinone substrates to less reactive and less toxic hydroquinone derivatives. The two-electron reduction of quinines bypasses semiquinone production and thus prevents the generation of reactive oxygen species (ROS) (2) . In addition, NQO1 activity was shown to maintain the reduced and active states of endogenous quinines, such as ·-tocopherol quinines and coenzyme Q derivatives, thereby promoting their antioxidant function in membrane (3) . Thus, NQO1 appears to protect against oxidative stress and carcinogenesis.
The NQO1 C609T genetic polymorphism has been found to exchange the Proline (P) at position 187 by Serine (S) and results in reduced levels of the NQO1 P187S protein by rapid turnover via the ubiquitin proteasomal pathway (2, 4) . Cells with the homozygous NQO1 609 T/T genotype have no measurable NQO1 enzyme activity. Several studies suggest an increased risk for cancers in the null genotype carriers, including breast cancers (5, 6) . Recently, the NQO1 genotype was suggested as a prognostic and predictive marker for breast cancer (7) . However, it is still unclear whether higher oxidative stress occurs in breast tissues of patients with the NQO1 609 C/T or T/T genotypes.
Human mitochondrial DNA (mtDNA) is a 16,569-bp circular double-stranded DNA molecule, which contains genes coding for 13 polypeptides involved in respiration and oxidative phosphorylation, 2 rRNAs and a set of 22 tRNAs that are essential for protein synthesis in mitochondria (8) .
The mitochondrial genome is particularly susceptible to oxidative damage and mutation by ROS and mutagens because of the high levels of ROS and free radical generation and inefficient DNA repair system in the organelle (9) (10) (11) .
MtDNA 4,977-bp deletion is one of the most frequently observed mtDNA mutations and has a 13 bp direct repeat flanking the 5'-and 3'-end breakpoints at nucleotide position (np) 8470/8482 and np 13447/13459, respectively (12) . It has been well established that mtDNA with the 4,977-bp deletion is accumulated with age in post-mitotic tissues of the human (13) and correlates with the oxidative modification (8-OHdG) content of mtDNA (14) . In addition, it is increased by environmental insults, such as UV irradiation (15) (16) (17) , cigarette smoking (18, 19) and betel quid chewing (20) . Moreover, the mtDNA 4,977-bp deletion is also frequently detected in various types of cancer tissues (20) (21) (22) (23) (24) . Due to its good correlation with oxidative damage levels in somatic tissues, we hypothesized that the mtDNA deletion would be more frequently detected in breast tissues of the patients with NQO1 609 C/T or T/T genotype than those with C/C genotype.
In this study, we examined the occurrence of the mtDNA 4,977-bp deletion in 60 breast cancers and corresponding non-cancerous breast tissues. The relationship between the mtDNA deletion and the NQO1 genetic polymorphism was analyzed.
Materials and methods
Collection of human breast tissues and DNA extraction. Sixty breast cancers and the adjacent non-cancer breast tissues were obtained from patients with their consent at Taipei Veterans General Hospital. In the 60 breast cancer patients, 32 cases were <50 years old (the early age group) and 28 patients were ≥50 years old (the older age group). The mtDNA alterations in the same set of samples have been reported previously (23) . All the tissues were kept in liquid nitrogen immediately after surgical resection according to a protocol approved by the medical Ethics Committee for conducting human research at the hospital. Total DNA of the tissues was extracted by the QIAamp DNA mini kit (Qiagen) according to the instructions of the manufacturer. The final DNA pellet was dissolved in doubly distilled water and stored at -30˚C until use.
Analysis of NQO1 C609T polymorphism. The NQO1 C609T genetic polymorphism was analyzed according to the published polymerase chain reaction (PCR)-based restriction fragment length polymorphism (PCR-RFLP) method (25) . The primers for the PCR reaction were NQO1 F: 5'-AGT GGC ATT CTG CAT TTC TGT G-3' and NQO1 R: 5'-GAT GGA CTT GCC CAA GTG ATG-3'. PCR was performed in an ABI GeneAmp PCR system 9700 DNA thermal cycler. The reactions were carried out for 35 cycles in a 50 μl reaction mixture containing 200 ng DNA, 200 μM of each dNTP, 40 pmol of each primer, 1.0 U of Taq DNA polymerase and 1X reaction buffer. The PCR cycles consisted of 15-sec denaturation at 94˚C, 15-sec annealing at 58˚C and 40-sec primer extension at 72˚C. Each PCR product was subjected to HinfI digestion. The C-to-T substitution at nucleotide 609 creates a HinfI restriction site.
The PCR product (273 bp) with C allele was digested to two fragments (188 and 85 bp), whereas the PCR product with T allele was digested to three fragments (151, 85 and 37 bp). The DNA fragments were separated by electrophoresis on a 3% agarose gel at 100 volts for 40 min and detected under UV trans-illumination after ethidium bromide staining.
Detection of the mtDNA 4,977-bp deletion. The 4,977-bp deletion of mtDNA was detected using the primers L8150 (5'-CCG GGG GTA TAC TAC GGT CA-3') and H13650 (5'-GGG GAA GCG AGG TTG ACC TG-3') (22) . PCR was performed in an ABI GeneAmp PCR System 9700 DNA thermal cycler. The reactions were carried out for 35 cycles in a 50 μl reaction mixture containing 200 ng DNA, 200 μM of each dNTP, 40 pmol of each primer, 1.0 U of Taq DNA polymerase and 1X reaction buffer. The PCR cycles consisted of 15-sec denaturation at 94˚C, 15-sec annealing at 58˚C and 40-sec primer extension at 72˚C. The PCR products were separated by electrophoresis on a 1.5% agarose gel at 100 volts for 40 min and detected under UV trans-illumination after ethidium bromide staining.
DNA sequencing of the mtDNA 4,977-bp deletion. The PCR products with the primers L8150 and H13650 were sequenced with an ABI PRISM 3100 DNA analyzer (Applied Biosystems) using a BigDye Terminator v1.1 cycle sequencing kit (Applied Biosystems) according to the manufacturer's instructions.
Statistical analysis.
Relationships between the mtDNA 4,977-bp deletion and NQO1 C609T polymorphisms were analyzed using the Statistical Program for Social Sciences (SPSS) program package. Fisher's exact test was used to compare the age and NQO1 genotypes. All statistical tests were two sided. The difference between groups was considered statistically significant at P<0.05.
Results
We adopted the PCR-RFLP method to characterize the NQO1 C609T polymorphisms in the 60 breast cancer patients (Fig. 1) . The NQO1 genotypes of these patients are summarized in Table I . The genotype frequencies of NQO1 C609T polymorphism in the 60 patients were C/C 31.7% (n=19), C/T 38.3% (n=23) and T/T 30.0% (n=18). The relationship between NQO1 609 genotypes and the clinicopathological parameters are summarized in Table II . No significant association was observed.
Moreover, mtDNA 4,977-bp deletion was detected in 29 (48.3%) non-tumor breast tissues of the 60 patients with breast cancer (Table I and Fig. 1 ). Only three (5%) of the breast cancer samples was found to carry the mtDNA deletion. The occurrence of the mtDNA deletion in non-tumor breast tissues was not correlated with the patient age (P=0.448), 5-year disease-free survival (P=0.480) or the 5-year overall survival (P=0.709). We further analyzed the DNA sequences and confirmed the 13 bp direct repeat flanking the 5'-and 3'-end breakpoints of the mtDNA deletion in three cases with NQO1 609 C/C, C/T and T/T genotypes, respectively (Fig. 2) .
Importantly, we found that 61.1% (11/18) of NQO1 T/T carriers and 65.2% (15/23) of NQO1 C/T carriers, but only 15.8% (3/19) of NQO1 C/C carriers had the mtDNA deletion in their non-cancerous breast tissues (Table III) . The mtDNA 4,977-bp deletion was more frequently detected in the breast tissues of the cancer patients with NQO1 C/T and T/T genotypes as compared with the patients with NQO1 C/C genotype (P=0.003). Similar results were observed in the <50 y/o group (P=0.06) and the ≥50 y/o group (P=0.005). Although no significant difference in the occurrence of the mtDNA deletion was observed between the two age groups (P=0.437), the deletion was more frequently detected in the ≥50 y/o group as compared with the <50 y/o group in the NQO1 C/T genotype (Fig. 2) .
Discussion
The NQO1 enzyme is suggested to play a role in protection against oxidative stress and carcinogenesis. In this study, we demonstrated for the first time that NQO1 609 C/T and T/T genotypes are associated with increased frequencies of mtDNA 4,977-bp deletion in breast tissues, implicating increased oxidative stress associated with NQO1 deficiency in carcinogenesis of breast cancer.
The common mtDNA 4,977-bp deletion has been shown to accumulate with age, primarily in postmitotic tissues (13) and cancers (20) (21) (22) (23) (24) . The different accumulation rate could result from genetic factors (such as tissue type), energy demand, intracellular oxidative stress levels, environmental insults, or cancer progression. Recently, hepatitis B virus-infected liver was observed to be correlated with the mtDNA deletion in the patients with hepatocellular carcinoma (26) , suggesting increased oxidative stress may contribute to accumulation of the deleted mtDNA in the non-cancerous tissue. In the present study, we found that the incidence of the 4,977-bp deletion in the non-cancerous breast cancer is significantly higher in the patients with NQO1 609 C/T and T/T genotypes as compared with the NQO1 609 C/C genotype cases. Because the NQO1 609 T/T genotype leads to a lack of NQO1 enzyme activity, our findings suggest that increased oxidative stress resulted from a lack of ROS scavenging function and/or of the capacity of maintaining antioxidant function of NQO1 thus possibly contributing to the increased incidence of the common mtDNA deletion.
We detected the common 4,977-bp deletion of mtDNA in only three breast cancers but in 47% of the non-cancerous breast tissues. The finding of lower incidence of the deletion in tumor than that in noncancerous tissue is consistent with those for different cancers (20) (21) (22) (23) (24) and with the evidence from a previous study in 17 breast cancer patients by microdissection of the tumor tissue and in situ PCR (27) . The common mtDNA deletion causes a loss of 5 tRNA genes and 7 genes encoding subunits of cytochrome oxidase, complex I and ATPase, and may have a strong functional disadvantage, possibly thereby repressing the growth of cancer cells harboring the deleted mtDNA. The decrease in the incidence of the common deletion in tumor indicates that there may be a dilution effect due to rapid cytoplasmic division or an active selection mechanism by which cancer cells harboring the deleted mtDNA would be eliminated because of apoptosis.
Estrogen has been proposed to play a critical role in breast cancer initiation. According to the epidemiologic studies, prolonged exposure to estrogen, including reduced fertility rate, earlier menarche, and prolonged reproductive stimulation in the lifetimes, is significantly associated with increased risk of female breast cancer in Taiwan and in Western countries (28, 29) . The oxidized metabolites of estrogen, E2-3,4-semiquinones and E2-3,4-quinones, have been shown to bind to DNA to form adducts, leading to genetic damage. In addition, the generation of ROS during the conversion of E2-3,4-semiquinones to E2-3,4-quinones can also lead to oxidative DNA damage. The NQO1 may have a critical role in protecting DNA from reactive catechol estrogens through a two-electron reduction of estrogen semiquinones and/or an increase in endogenous antioxidant function, such as ·-tocopherol quinines and coenzyme Q derivatives. Because the NQO1 609 T/T genotype leads to a lack of NQO1 enzyme activity, it is possible that increased oxidative stress-associated estrogen exposure in the individuals with NQO1 609 T/T genotype Table I . Summary of mtDNA 4,977-bp deletion and NQO1 609 genotypes in 60 patients with primary breast cancers. --------------------------------------------- -257  37  CC  --314  78  TT  +  +  324  73  CC  --340  72  TT  +  -349  51  CT  +  -350  35  CT  --371  76  CT  +  -375  63  CT  +  -377  46  CT  --381  49  CC  --383  55  CT  +  -385  46  TT  --386  59  CC  --387  35  CC  --416  25  CT  --420  50  CC  --425  87  CC  --430  59  CT  +  -432  28  TT  +  -438  54  CC  +  -440  38  CT  +  -446  37  TT  +  -447  54  CC  +  -451  38  CT  +  -464  41  TT  +  -489  74  TT  --498  61  CT  --501  40  TT  --510  41  CC  +  -511  42  CT  +  -529  39  CT  --546  35  TT  +  -621  35  CT  +  -651  75  CT  +  -692  71  CT  +  -717  35  CT  --732  65  CC  --739  52  CC  --760  46  CC  --765  61  CT  --776  52  TT  --777  56  CT  +  +  779  63  CC  --780  36  CC  --781  43  TT  --797  36  TT  +  -801  52  CT  +  +  806  50  CC  --807  47  TT  +  -871  55  CC  --900  38  TT  +  -954  39  TT  --955 75 CT + - Table I . Continued. --958  75  CT  +  -961  38  TT  +  -1099  36  CC  --1113  28  TT  --1133  33  CC  --1154  36  TT  +  -1215 38
Tu, tumor portion; N, non-tumorous portion and y/o, years old. Table II . Clinicopathological features of the breast cancer patients with NQO1 C609T polymorphism. Stage  I  9  5  2  2  II  25  7  7  11  III  21  5  12  4  IV  5 
ER, estrogen receptor and PR, progesterone receptor. Table III . Incidence of mtDNA 4,977-bp deletion in non-cancerous breast tissue of 60 breast cancer patients with NQO1 609 genotypes.
<50 years old ≥50 years old Total -----------------------------------------------------------------NQO1 609 genotype 4,977-bp deletion 4,977-bp deletion 4,977-bp deletion -----------------n -+ P -+ P -+ C/C  19  7  1  9  2  16  3  C/T  23  6  4  2  11  8  15  T/T  18  5  9  2  2  7  11  18  14  0.06  13  15  0.005  31  29 0
P-value -----------------------------------------------------------------------------------------------------

.003 -----------------------------------------------------------------------------------------------------
-, negative; +, positive.
- ---------------------------------------------------------------------------------------------------- could lead to an increased burden of mtDNA mutation. Moreover, the prevalence of the C609T polymorphism reported here (68.3%) and reported previously in Chinese (66.0-69.5%) (5,30) is higher than that of Caucasians (26%) (30) . The higher prevalence of the NQO1 genetic polymorphism could contribute to the higher incidence of breast cancer in younger age women in Taiwan than their counterparts in Western countries.
In conclusion, our study provided direct evidence that the occurrence of the mtDNA 4,977-bp deletion was higher in the breast tissues of NQO1 609 C/T and T/T carriers as compared with NQO1 609 C/C patients. Our findings suggest that increased oxidative stress is associated with the lack of antioxidant function of NQO1 and may be involved in tumorigenesis of breast cancer.
